Published in

Elsevier, Annals of Oncology, 8(27), p. 1625-1632, 2016

DOI: 10.1093/annonc/mdw225

Links

Tools

Export citation

Search in Google Scholar

Adjuvant treatment with pegylated interferon α-2a versus low-dose interferon α-2a in patients with high-risk melanoma: a randomized phase III DeCOG trial

Journal article published in 2016 by T. K. Eigentler, R. Gutzmer, A. Hauschild, L. Heinzerling, D. Schadendorf, D. Nashan, E. Hölzle, F. Kiecker, J. Becker, C. Sunderkötter, I. Moll, E. Richtig, I. Pönitzsch, H. Pehamberger, R. Kaufmann and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO